Skip to main content

Table 1 Baseline demographics and disease characteristics (treated set)

From: A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids

  Total
Patients, n (%) 101 (100)
  Male 69 (68.3)
  Female 32 (31.7)
Race, n (%)  
  White 101 (100)
Age (years), mean ± SD 8.8 ± 1.7
  6–8 years, n (%) 37 (36.6)
  9–11 years, n (%) 64 (63.4)
Weight (kg), mean ± SD 34.2 ± 10.5
Height (cm), mean ± SD 138.9 ± 12.2
BMI (kg/m2), mean ± SD 17.4 ± 3.2
Smoking exposure, n (%)  
  No exposure 95 (94.1)
  Exposure to household/second-hand smoking 6 (5.9)
Duration of asthma (years), mean ± SD 4.5 ± 2.3
  <1 year’s duration, n (%) 6 (5.9)
  1–< 3 years’ duration, n (%) 18 (17.8)
  ≥3 years’ duration, n (%) 77 (76.2)
  1. BMI, body mass index; SD, standard deviation.